Creative Medical Technology Holdings, Inc. Dividend, Share-based Payment Arrangement
Creative Medical Technology Holdings, Inc. (CELZ) reported Dividend, Share-based Payment Arrangement of $595.38 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Shareholders' Equity › Dividends
us-gaap:DividendsShareBasedCompensation · last filed 2022-03-30
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for the quarter ending 2021-09-30 was $383.61K, a 462.13% increase year-over-year.
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for the quarter ending 2020-12-31 was $102.08K.
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for the quarter ending 2020-09-30 was $68.24K.
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for fiscal 2021 was $595.38K, a 249.56% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. dividend, share-based payment arrangement for fiscal 2020 was $170.32K.
| Period end | Dividend, Share-based Payment Arrangement 3 month | Dividend, Share-based Payment Arrangement 6 month | Dividend, Share-based Payment Arrangement 9 month | Dividend, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $383.61K derived: sum of 2 quarters · filed 2022-03-30 | $595.38K 10-K · filed 2022-03-30 | |
| 2021-09-30 | $383.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $595.38K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $211.77K 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $102.08K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $170.32K derived: sum of 2 quarters · filed 2022-03-30 | $170.32K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $68.24K 10-Q · filed 2020-11-13 | $68.24K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |